Delafloxacin meglumine
Drug ingredientCAS 352458-37-8
This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
US productionNot reported
Top sourceNo public record
This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.
Why supply is unknownWhere It Comes From
EPA and Census publish no US supply data for this chemical.
3 FDA-registered drug labelers
Melinta Therapeutics, LLC
Patheon Italia S.p.A.
ScinoPharm Taiwan Ltd.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 1 drug and cosmetic product listings (FDA).
- •Baxdela
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS352458-37-8
PubChem CID11578213
DTXSIDDTXSID90188740
FormulaC25H29ClF3N5O9
Mol. Weight636 g/mol
SMILESCNCC(C(C(C(CO)O)O)O)O.C1C(CN1C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4=C(C=C(C(=N4)N)F)F)F)O
Data Sources
- PubChem · compound 11578213Retrieved 2026-04-07
- FDA National Drug Code directoryRetrieved 2026-04-25
- FDA National Drug Code directoryRetrieved 2026-04-07
Brief citations
Delafloxacin meglumine (CAS 352458-37-8) https://chemicalindependence.com/chemical/352458-37-8/ PubChem: 11578213. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/11578213 FDA National Drug Code directory: CAS 352458-37-8. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA National Drug Code directory: bulk match. Retrieved 2026-04-07. https://open.fda.gov/data/ndc/